IAMA Therapeutics, a preclinical-stage pharmaceutical company focused on the discovery, development, and commercialization of novel medicines to make a difference in the lives of individuals suffering
Rigaku continues to provide access to their ResQ CQL handheld Raman spectrometers, designed for frontline defence against chemical and biological threats.
Two Yale University schools have partnered with the University of Rome Tor Vergata (URTV) to advance research and training intended to improve global protection against chemical, biological, radiological, nuclear, and explosives (CBRNe) events. The collaboration involves researchers at the Yale School of Public Health (YSPH) and Yale School of Medicine (YSM) along with faculty